Relation between the vitamin D status and the occurrence and severity of thyroid malignancy

Main Article Content

L.A. Nikitiuk
Korsak Yu.

Abstract

Background. In spite of large volume of data linking vitamin D with cardiovascular morbidity, autoimmunity, cancer, and virtually every organ system, vitamin D and thyroid is a lesser-known aspect of vitamin D in clinical practice. The association between vitamin D deficiency and thyroid cancer is controversial. Some studies have demonstrated that higher serum vitamin D levels might protect against thyroid cancer, whereas others have not, or have even indicated the opposite to to be the case. This review intends to highlight the current literature on the impact of vitamin D status on thyroid cancer. Materials and methods. References for this review were identified through searches of PubMed for articles published to from 2005 to June 2021 using the terms “thyroid cancer” and “vitamin D”. Results. A large volume of medical literature is available from observational studies linking vitamin D with thyroid cancer. Data from interventional studies documenting beneficial effects of vitamin D on thyroid autoimmunity is also available, but lesser than that from observational studies. Short-term high dose oral vitamin D supplementation reduces TPOAb titers. Certain vitamin D receptor (VDR) gene polymorphism have been linked to increased occurrence of autoimmune thyroid disorders. Vitamin D deficiency, decreased circulating calcitriol has been linked to increased thyroid cancer. Certain VDR gene polymorphisms have been linked with increased as well as decreased occurrence of thyroid cancer. Data is scant on use of vitamin D and its analogues for treating thyroid cancer. The results suggest that Vitamin D deficiency may have value as a negative prognostic indicator in papillary thyroid cancer and that pre-operative laboratory evaluation may be less useful. This is important because Vitamin D deficiency is modifiable. Conclusions. In spite of large volume of medical literature from observational studies linking vitamin D with thyroid cancer, meaningful concrete clinical data on impact of vitamin D supplementation on hard clinical end points in these disorders is lacking, and should be the primary area of research in the next decade.

Article Details

How to Cite
Nikitiuk, L., and K. Yu. “Relation Between the vitamin D Status and the Occurrence and Severity of Thyroid Malignancy”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 17, no. 7, Jan. 2022, pp. 557-61, doi:10.22141/2224-0721.17.7.2021.244971.
Section
Original Researches

References

Zmijewski MA. Vitamin D and Human Health. Int J Mol Sci. 2019 Jan 3;20(1):145. doi: 10.3390/ijms20010145.

Kim DH, Meza CA, Clarke H, Kim JS, Hickner RC. Vitamin D and Endothelial Function. Nutrients. 2020 Feb 22;12(2):575. doi: 10.3390/nu12020575.

Szymczak-Pajor I, Śliwińska A. Analysis of Association between Vitamin D Deficiency and Insulin Resistance. Nutrients. 2019 Apr 6;11(4):794. doi: 10.3390/nu11040794.

Dutta D, Sharma M, Aggarwal S, Mohindra R, Bhattacharya S, Kalra S. Vitamin D, Thyroid Autoimmunity and Cancer: An Interplay of Different Factors. Indian J Endocrinol Metab. 2019 Sep-Oct;23(5):507-513. doi: 10.4103/ijem.IJEM_526_19.

Fathi N, Ahmadian E, Shahi S, et al. Role of vitamin D and vitamin D receptor (VDR) in oral cancer. Biomed Pharmacother. 2019 Jan;109:391-401. doi: 10.1016/j.biopha.2018.10.102.

Du L, Wang Y, Sun X, Li H, Geng X, Ge M, Zhu Y. Thyroid cancer: trends in incidence, mortality and clinical-pathological patterns in Zhejiang Province, Southeast China. BMC Cancer. 2018 Mar 15;18(1):291. doi: 10.1186/s12885-018-4081-7.

Olson E, Wintheiser G, Wolfe KM, Droessler J, Silberstein PT. Epidemiology of Thyroid Cancer: A Review of the National Cancer Database, 2000-2013. Cureus. 2019 Feb 24;11(2):e4127. doi: 10.7759/cureus.4127.

Miranda-Filho A, Lortet-Tieulent J, Bray F, et al. Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Lancet Diabetes Endocrinol. 2021 Apr;9(4):225-234. doi: 10.1016/S2213-8587(21)00027-9.

Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM. Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013. JAMA. 2017 Apr 4;317(13):1338-1348. doi: 10.1001/jama.2017.2719.

Olson E, Wintheiser G, Wolfe KM, Droessler J, Silberstein PT. Epidemiology of Thyroid Cancer: A Review of the National Cancer Database, 2000-2013. Cureus. 2019 Feb 24;11(2):e4127. doi: 10.7759/cureus.4127.

Heidari Z, Abdani M, Mansournia MA. Insulin Resistance Associated With Differentiated Thyroid Carcinoma: Penalized Conditional Logistic Regression Analysis of a Matched Case-Control Study Data. Int J Endocrinol Metab. 2017 Oct 25;16(1):e14545. doi: 10.5812/ijem.14545.

Jeon SM, Shin EA. Exploring vitamin D metabolism and function in cancer. Exp Mol Med. 2018 Apr 16;50(4):1-14. doi: 10.1038/s12276-018-0038-9.

Sulibhavi A, Rohlfing ML, Jalisi SM, et al. Vitamin D deficiency and its relationship to cancer stage in patients who underwent thyroidectomy for papillary thyroid carcinoma. Am J Otolaryngol. 2019 Jul-Aug;40(4):536-541. doi: 10.1016/j.amjoto.2019.04.013.

Roskies M, Dolev Y, Caglar D, et al. Vitamin D deficiency as a potentially modifiable risk factor for thyroid cancer. J Otolaryngol Head Neck Surg. 2012 Jun 1;41(3):160-3.

Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ. The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer. 2014 May;14(5):342-57. doi: 10.1038/nrc3691.

Díaz L, Díaz-Muñoz M, García-Gaytán AC, Méndez I. Mechanistic Effects of Calcitriol in Cancer Biology. Nutrients. 2015 Jun 19;7(6):5020-50. doi: 10.3390/nu7065020.

Clinckspoor I, Verlinden L, Mathieu C, Bouillon R, Verstuyf A, Decallonne B. Vitamin D in thyroid tumorigenesis and development. Prog Histochem Cytochem. 2013 Aug;48(2):65-98. doi: 10.1016/j.proghi.2013.07.001.

Peng W, Wang K, Zheng R, Derwahl M. 1,25 dihydroxyvitamin D3 inhibits the proliferation of thyroid cancer stem-like cells via cell cycle arrest. Endocr Res. 2016 May;41(2):71-80. doi: 10.3109/07435800.2015.1037048.

Sharma V, Fretwell D, Crees Z, Kerege A, Klopper JP. Thyroid cancer resistance to vitamin D receptor activation is associated with 24-hydroxylase levels but not the ff FokI polymorphism. Thyroid. 2010 Oct;20(10):1103-11. doi: 10.1089/thy.2010.0096.

Morand GB, da Silva SD, Hier MP, Alaoui-Jamali MA. Insights into genetic and epigenetic determinants with impact on vitamin d signaling and cancer association studies: the case of thyroid cancer. Front Oncol. 2014 Nov 4;4:309. doi: 10.3389/fonc.2014.00309.

Roskies M, Dolev Y, Caglar D, et al. Vitamin D deficiency as a potentially modifiable risk factor for thyroid cancer. J Otolaryngol Head Neck Surg. 2012 Jun 1;41(3):160-3.

Sahin M, Uçan B, Giniş Z, et al. Vitamin D3 levels and insulin resistance in papillary thyroid cancer patients. Med Oncol. 2013;30(2):589. doi: 10.1007/s12032-013-0589-5.

Kim JR, Kim BH, Kim SM, et al. Low serum 25 hydroxyvitamin D is associated with poor clinicopathologic characteristics in female patients with papillary thyroid cancer. Thyroid. 2014 Nov;24(11):1618-24. doi: 10.1089/thy.2014.0090.

Penna-Martinez M, Ramos-Lopez E, Stern J, et al. Vitamin D receptor polymorphisms in differentiated thyroid carcinoma. Thyroid. 2009 Jun;19(6):623-8. doi: 10.1089/thy.2008.0388.

Penna-Martinez M, Ramos-Lopez E, Stern J, et al. Impaired vitamin D activation and association with CYP24A1 haplotypes in differentiated thyroid carcinoma. Thyroid. 2012 Jul;22(7):709-16. doi: 10.1089/thy.2011.0330.

Ahn HY, Chung YJ, Park KY, Cho BY. Serum 25-Hydroxyvitamin D Level Does Not Affect the Aggressiveness and Prognosis of Papillary Thyroid Cancer. Thyroid. 2016 Mar;26(3):429-33. doi: 10.1089/thy.2015.0516.

Danilovic DL, Ferraz-de-Souza B, Fabri AW, et al. 25-Hydroxyvitamin D and TSH as Risk Factors or Prognostic Markers in Thyroid Carcinoma. PLoS One. 2016 Oct 13;11(10):e0164550. doi: 10.1371/journal.pone.0164550.

Choi YM, Kim WG, Kim TY, et al. Serum vitamin D3 levels are not associated with thyroid cancer prevalence in euthyroid subjects without autoimmune thyroid disease. Korean J Intern Med. 2017 Jan;32(1):102-108. doi: 10.3904/kjim.2015.090.

Warakomski J, Romuk E, Jarząb B, Krajewska J, Siemińska L. Concentrations of Selected Adipokines, Interleukin-6, and Vitamin D in Patients with Papillary Thyroid Carcinoma in Respect to Thyroid Cancer Stages. Int J Endocrinol. 2018 Dec 3;2018:4921803. doi: 10.1155/2018/4921803.

Zhao J, Wang H, Zhang Z, et al. Vitamin D deficiency as a risk factor for thyroid cancer: A meta-analysis of case-control studies. Nutrition. 2019 Jan;57:5-11. doi: 10.1016/j.nut.2018.04.015.

Sulibhavi A, Rohlfing ML, Jalisi SM, et al. Vitamin D deficiency and its relationship to cancer stage in patients who underwent thyroidectomy for papillary thyroid carcinoma. Am J Otolaryngol. 2019 Jul-Aug;40(4):536-541. doi: 10.1016/j.amjoto.2019.04.013.

Bains A, Mur T, Wallace N, Noordzij JP. The Role of Vitamin D as a Prognostic Marker in Papillary Thyroid Cancer. Cancers (Basel). 2021 Jul 14;13(14):3516. doi: 10.3390/cancers13143516.

Krasniqi E, Boshnjaku A, Wagner KH, Wessner B. Association between Polymorphisms in Vitamin D Pathway-Related Genes, Vitamin D Status, Muscle Mass and Function: A Systematic Review. Nutrients. 2021 Sep 4;13(9):3109. doi: 10.3390/nu13093109.

Clendenen TV, Ge W, Koenig KL, et al. Genetic Polymorphisms in Vitamin D Metabolism and Signaling Genes and Risk of Breast Cancer: A Nested Case-Control Study. PLoS One. 2015 Oct 21;10(10):e0140478. doi: 10.1371/journal.pone.0140478.

Penna-Martinez M, Ramos-Lopez E, Stern J, et al. Vitamin D receptor polymorphisms in differentiated thyroid carcinoma. Thyroid. 2009 Jun;19(6):623-8. doi: 10.1089/thy.2008.0388.

Hoseinkhani Z, Rastegari-Pouyani M, Tajemiri F, Yari K, Mansouri K. Association of Vitamin D Receptor Polymorphisms (FokI (Rs2228570), ApaI (Rs7975232), BsmI (Rs1544410), and TaqI (Rs731236)) with Gastric Cancer in a Kurdish Population from West of Iran. Rep Biochem Mol Biol. 2021 Jan;9(4):435-441. doi: 10.52547/rbmb.9.4.435.

Pankiv I. The Impact of Vitamin D Status and Supplementation on Thyroid Autoimmunity. International Journal of Endocrinology (Ukraine). 2021;16(8):681-685. doi: 10.22141/2224-0721.16.8.2020.222889.

Mele C, Caputo M, Bisceglia A, et al. Immunomodulatory Effects of Vitamin D in Thyroid Diseases. Nutrients. 2020 May 16;12(5):1444. doi: 10.3390/nu12051444.

Most read articles by the same author(s)